Chemical activators of IQCA can play a significant role in modulating its activity through various biochemical pathways that lead to its functional activation. Forskolin, by directly activating adenylate cyclase, increases the levels of cAMP within the cell, a crucial secondary messenger in cellular signaling. The rise in cAMP levels can subsequently activate protein kinase A (PKA), which, through a cascade of phosphorylation events, can target and activate IQCA. Similar to Forskolin, 8-Bromo-cAMP and Dibutyryl cAMP, both being analogs of cAMP, directly activate PKA, which then phosphorylates and activates IQCA. Phorbol 12-myristate 13-acetate (PMA) engages another pivotal kinase, protein kinase C (PKC), which is known to phosphorylate substrates involved in the same signaling pathways as IQCA, thus facilitating its activation.
The intracellular calcium concentration is another determinant of IQCA activation, which is modulated by chemicals like Ionomycin and A23187, both of which are calcium ionophores. By increasing intracellular calcium levels, these compounds can activate calmodulin-dependent kinases capable of phosphorylating and activating IQCA. Thapsigargin contributes to the increase in cytosolic calcium by inhibiting the SERCA pump, leading to a similar activation route for IQCA. Inhibition of protein phosphatases by compounds such as Okadaic Acid and Calyculin A also results in a net increase in protein phosphorylation within the cell. This effect can lead to the sustained activation of IQCA due to the reduced dephosphorylation of proteins in its signaling network. Anisomycin, through the activation of stress-activated protein kinases, and Epigallocatechin Gallate (EGCG), which can activate AMP-activated protein kinase (AMPK), both influence kinases that phosphorylate proteins in pathways shared with IQCA. Lastly, Ouabain, by inhibiting Na+/K+-ATPase, initiates a series of signal transduction events culminating in the activation of kinases that can phosphorylate and activate IQCA. These diverse chemicals, through their unique mechanisms, coalesce on the common endpoint of enhancing the phosphorylation state of IQCA, driving its activation.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinases, which are known to phosphorylate substrates within IQCA's signaling cascade, leading to IQCA activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and activate IQCA as part of signal transduction pathways that IQCA is involved in. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatases, leading to increased phosphorylation levels of proteins. This inhibition can facilitate the activation of IQCA through enhanced phosphorylation by upstream kinases. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A is a potent inhibitor of protein phosphatases. Its action can result in the activation of IQCA by maintaining phosphorylation states that favor its active form. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog that activates PKA. PKA can then activate IQCA through phosphorylation within the cAMP signaling pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore that increases intracellular calcium, thereby potentially activating calcium-sensitive kinases that lead to IQCA activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can activate AMP-activated protein kinase (AMPK). Activated AMPK has been shown to phosphorylate various proteins in the same pathways as IQCA, which can lead to IQCA activation. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates stress-activated protein kinases (SAPKs), which can phosphorylate target proteins within IQCA's signaling networks, potentially leading to its activation. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+-ATPase pump, which alters ion gradients and activates signal transduction pathways that can lead to the activation of IQCA through phosphorylation by kinases activated in this context. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is another synthetic analog of cAMP that bypasses membrane receptors to directly activate PKA, resulting in phosphorylation cascades that include the activation of IQCA. | ||||||